Attorney for Yaz and Yasmin Patients Asks FDA to Ban the Contraceptive Drugs

Share Article

Phoenix Attorney Van O’Steen has asked the federal Food and Drug Administration (FDA) to ban Yaz, Yasmin and all other birth control pills containing the progestin drospirenone. O’Steen’s law firm, O’Steen & Harrison, PLC, represents patients throughout the United States who claim to have been seriously harmed by Bayer Healthcare’s top selling contraceptive medications.

Van O'Steen

It is well past time that Yaz, Yasmin and other drospirenone drugs were removed from the market.

Phoenix Attorney Van O’Steen has asked the federal Food and Drug Administration (FDA) to ban Yaz, Yasmin and all other birth control pills containing the progestin drospirenone. O’Steen’s law firm, O’Steen & Harrison, PLC, represents patients throughout the United States who claim to have been seriously harmed by Bayer Healthcare’s top selling contraceptive medications.

In a letter to the FDA dated November 8, 2011, O’Steen wrote, “I need not summarize here the body of evidence which demonstrates that these drugs place women who use them at higher risk for blood clots, strokes and other serious health problems than do other birth control pills. The FDA is fully aware of the research and numerous reports of adverse events.”

O’Steen notes that in 2002 the consumer watchdog group Public Citizen listed Yasmin as a Do Not Use drug. In 2007, it petitioned the FDA to ban Yaz. Last month, the FDA released the latest study report which reveals that, on average, women taking Yaz were at a 75% greater risk of experiencing a blood clot than were women taking older birth control medications that did not contain drospirenone.

Yaz, Yasmin and other newer contraceptive drugs containing drospirenone are commonly referred to as “third-generation” birth control pills. Older drugs containing other progestins are equally effective, less expensive and demonstrably safer, according to O’Steen’s letter to the FDA.

Dr. Diana Zuckerman, President of the National Center for Women and Families, best summarized the case for an FDA ordered ban on Yaz, Yasmin and other drospirenone-containing birth control drugs when she wrote, “At a certain point we have to ask why the FDA continues to approve drugs that are less safe and have no benefit compared to drugs already on the market. With all these different birth control options, why take the most expensive one that can also kill you?”

“It is well past time that Yaz, Yasmin and other drospirenone drugs were removed from the market,” O’Steen concluded.

Women who believe they may have been harmed by Yaz, Yasmin or similar birth control drugs are encouraged by O’Steen to consult their physicians, report their experiences to the FDA at http://www.fda.gov, and discuss their legal rights with an attorney experienced in Yaz and Yasmin litigation. For more information, see http://www.yazdefect.com.

About O’Steen & Harrison, PLC

O’Steen & Harrison, PLC has protected the rights of injured accident victims and their family members since 1974. The firm concentrates on personal injury, medical malpractice and dangerous products with a special emphasis on harmful drugs and defective medical devices. O’Steen & Harrison is av-rated (the highest rating) by the prestigious Martindale-Hubbell Law Directory. The firm’s attorneys have recovered more than $3 billion dollars for clients. O’Steen & Harrison offers free, confidential consultations to women nationwide who have taken Yaz, Yasmin and other drospirenone drugs. Call toll free 1-800-883-8888 or see our web site at http://www.yazdefect.com.

RESOURCES: Letter from Van O’Steen to U.S. FDA dated November 8, 2011; http://www.yazdefect.com; “Do Not Use! The New Birth Control Pill Drospirenone with Ethinyl Estradiol (YASMIN),” Worst Pills, Best Pills Newsletter, April 2002; “Public Citizen Wants Yasmin Birth Control Banned,” Lawyers and Settlements.com, June 27, 2009; “FDA Drug Safety Communication,” http://www.fda.gov/Drugs/DrugSafety/ucm277346.htm; “Birth-control pills tied to dangerous clots: which brands?” NRC For Women and Families, October 27, 2011.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Van O'Steen